Trgovina Regeneron Pharmaceuticals, Inc. - REGN CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Razmik | 1.04 | ||||||||
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.024068% | ||||||||
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | 0.001846% | ||||||||
Čas nočne pristojbine | 21:00 (UTC) | ||||||||
Min. tržena količina | 1 | ||||||||
Valuta | USD | ||||||||
Kritje | 20% | ||||||||
Borza | United States of America | ||||||||
Provizija na trgovanje | 0% |
*Information provided by Capital.com
Regeneron Pharmaceuticals Inc ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Predhodno. Zapri* | 826.3 |
Odpri* | 830.55 |
Enoletna sprememba* | 19.91% |
Dnevni razpon* | 818.92 - 830.55 |
Razpon 52 wk | 538.01-832.48 |
Povprečni obseg (10 dni) | 816.08K |
Povprečni obseg (3 meseci) | 13.25M |
Tržna kapitalizacija | 89.69B |
Razmerje P/E | 21.46 |
Število delnic v obtoku | 109.33M |
Prihodki | 12.17B |
EPS | 38.24 |
Dividenda (donosnost v %) | N/A |
Beta | 0.22 |
Datum naslednjega zaslužka | May 2, 2023 |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
---|---|---|---|---|---|---|
Mar 28, 2023 | 826.30 | 16.39 | 2.02% | 809.91 | 826.85 | 809.91 |
Mar 27, 2023 | 819.49 | -0.34 | -0.04% | 819.83 | 831.72 | 812.36 |
Mar 24, 2023 | 819.63 | 17.38 | 2.17% | 802.25 | 823.61 | 795.78 |
Mar 23, 2023 | 801.72 | -1.10 | -0.14% | 802.82 | 811.60 | 787.54 |
Mar 22, 2023 | 750.68 | -8.68 | -1.14% | 759.36 | 764.03 | 750.15 |
Mar 21, 2023 | 758.90 | 0.41 | 0.05% | 758.49 | 764.47 | 750.58 |
Mar 20, 2023 | 758.21 | 16.55 | 2.23% | 741.66 | 759.65 | 741.65 |
Mar 17, 2023 | 747.35 | 1.81 | 0.24% | 745.54 | 753.70 | 740.70 |
Mar 16, 2023 | 748.89 | -2.86 | -0.38% | 751.75 | 752.05 | 725.56 |
Mar 15, 2023 | 759.88 | 7.50 | 1.00% | 752.38 | 765.58 | 752.38 |
Mar 14, 2023 | 766.66 | 13.56 | 1.80% | 753.10 | 769.29 | 753.01 |
Mar 13, 2023 | 752.05 | 6.55 | 0.88% | 745.50 | 768.02 | 740.46 |
Mar 10, 2023 | 746.30 | 2.75 | 0.37% | 743.55 | 758.66 | 736.92 |
Mar 9, 2023 | 743.15 | -1.92 | -0.26% | 745.07 | 755.33 | 738.07 |
Mar 8, 2023 | 744.62 | -27.39 | -3.55% | 772.01 | 772.76 | 743.57 |
Mar 7, 2023 | 773.11 | -7.63 | -0.98% | 780.74 | 782.86 | 770.56 |
Mar 6, 2023 | 779.91 | 5.06 | 0.65% | 774.85 | 785.00 | 768.08 |
Mar 3, 2023 | 778.57 | 13.47 | 1.76% | 765.10 | 779.63 | 764.97 |
Mar 2, 2023 | 767.91 | -0.13 | -0.02% | 768.04 | 772.37 | 760.64 |
Mar 1, 2023 | 769.69 | 15.12 | 2.00% | 754.57 | 772.43 | 754.57 |
Regeneron Pharmaceuticals, Inc. Events
Čas (UTC) (UTC) | Država | Dogodek |
---|---|---|
No events scheduled |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Skupni prihodki | 12172.9 | 16071.7 | 8497.1 | 7863.4 | 6710.8 |
Prihodki | 12172.9 | 16071.7 | 8497.1 | 7863.4 | 6710.8 |
Celotni stroški prihodkov | 1560.4 | 2437.5 | 1119.9 | 782.2 | 434.1 |
Bruto dobiček | 10612.5 | 13634.2 | 7377.2 | 7081.2 | 6276.7 |
Celotni odhodki iz poslovanja | 7434 | 7124.9 | 4920.5 | 5653.6 | 4176.4 |
Celotna prodaja/splošni/upravni stroški Odhodki | 2115.9 | 1824.9 | 1346 | 1834.8 | 1556.2 |
Raziskave in razvoj | 3592.5 | 2908.1 | 2735 | 3036.6 | 2186.1 |
Prihodki iz poslovanja | 4738.9 | 8946.8 | 3576.6 | 2209.8 | 2534.4 |
Prihodki (odhodki) od obresti, neto Neoperativni | -19.6 | 328.8 | 139.1 | 88.1 | 13.7 |
Drugo, neto | 139.5 | 50.2 | 94.7 | 131.2 | 5.4 |
Čisti dobiček pred obdavčitvijo | 4858.8 | 9325.8 | 3810.4 | 2429.1 | 2553.5 |
Čisti dobiček po davkih | 4338.4 | 8075.3 | 3513.2 | 2115.8 | 2376.4 |
Čisti dobiček pred dodatnimi postavkami | 4338.4 | 8075.3 | 3513.2 | 2115.8 | 2376.4 |
Čisti dobiček | 4338.4 | 8075.3 | 3513.2 | 2115.8 | 2444.4 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | 4338.4 | 8075.3 | 3513.2 | 2115.8 | 2376.4 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | 4338.4 | 8075.3 | 3513.2 | 2115.8 | 2444.4 |
Prilagoditev za redčenje | |||||
Popravljen čisti dobiček | 4338.4 | 8075.3 | 3513.2 | 2115.8 | 2444.4 |
Popravljene ponderirane povprečne delnice | 113.5 | 112.2 | 115.1 | 114.6 | 114.8 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | 38.2238 | 71.9724 | 30.523 | 18.4625 | 20.7003 |
Dividends per Share - Common Stock Primary Issue | |||||
Popravljen normalizirani dobiček na enoto čistega dobička | 40.4714 | 71.9724 | 30.523 | 18.4625 | 20.7003 |
Skupaj izredne postavke | 68 | ||||
Other Operating Expenses, Total | -89.9 | -45.6 | -280.4 | ||
Nenavadni odhodki (prihodki) | 255.1 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Skupni prihodki | 3414.4 | 2936.2 | 2857.2 | 2965.1 | 4951.7 |
Prihodki | 3414.4 | 2936.2 | 2857.2 | 2965.1 | 4951.7 |
Celotni stroški prihodkov | 540.6 | 317.8 | 297.1 | 404.9 | 982.6 |
Bruto dobiček | 2873.8 | 2618.4 | 2560.1 | 2560.2 | 3969.1 |
Celotni odhodki iz poslovanja | 2267.6 | 1712.5 | 1747.3 | 1706.6 | 2312 |
Celotna prodaja/splošni/upravni stroški Odhodki | 660.5 | 529.1 | 476.3 | 450 | 559.6 |
Raziskave in razvoj | 1043.1 | 911.3 | 794.3 | 843.8 | 785.6 |
Other Operating Expenses, Total | -6.6 | -45.7 | -17.4 | -20.2 | -15.8 |
Prihodki iz poslovanja | 1146.8 | 1223.7 | 1109.9 | 1258.5 | 2639.7 |
Prihodki (odhodki) od obresti, neto Neoperativni | 143 | 239 | -176.8 | -224.8 | -151.8 |
Drugo, neto | 34.9 | 47.1 | 30.1 | 27.4 | 15.5 |
Čisti dobiček pred obdavčitvijo | 1324.7 | 1509.8 | 963.2 | 1061.1 | 2503.4 |
Čisti dobiček po davkih | 1197.1 | 1315.7 | 852.1 | 973.5 | 2229 |
Čisti dobiček pred dodatnimi postavkami | 1197.1 | 1315.7 | 852.1 | 973.5 | 2229 |
Čisti dobiček | 1197.1 | 1315.7 | 852.1 | 973.5 | 2229 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | 1197.1 | 1315.7 | 852.1 | 973.5 | 2229 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | 1197.1 | 1315.7 | 852.1 | 973.5 | 2229 |
Popravljen čisti dobiček | 1197.1 | 1315.7 | 852.1 | 973.5 | 2229 |
Popravljene ponderirane povprečne delnice | 114.1 | 112.8 | 114 | 113.1 | 113.4 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | 10.4917 | 11.664 | 7.47456 | 8.60743 | 19.6561 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
Popravljen normalizirani dobiček na enoto čistega dobička | 10.7546 | 11.664 | 9.20263 | 8.85588 | 19.6561 |
Nenavadni odhodki (prihodki) | 30 | 0 | 197 | 28.1 |
- Letni
- Četrtletno
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 14014.9 | 9779.1 | 7689.1 | 6447.6 | 4335.03 |
Denarna sredstva in kratkoročne naložbe | 5694.7 | 3587 | 3214.3 | 2809.9 | 1409.58 |
Denarna sredstva in ustrezniki | 2885.6 | 2193.7 | 1617.8 | 1467.7 | 812.733 |
Kratkoročne naložbe | 2809.1 | 1393.3 | 1596.5 | 1342.2 | 596.847 |
Celotne terjatve, neto | 6036.5 | 4114.7 | 2672.2 | 2243.2 | 1974.34 |
Accounts Receivable - Trade, Net | 6036.5 | 4114.7 | 2672.2 | 2243.2 | 1974.34 |
Total Inventory | 1502.8 | 1485.7 | 1014.6 | 822.3 | 513.878 |
Prepaid Expenses | 332.4 | 160.8 | 387.1 | 243.3 | 224.972 |
Other Current Assets, Total | 448.5 | 430.9 | 400.9 | 328.9 | 212.26 |
Total Assets | 25434.8 | 17163.3 | 14805.2 | 11734.5 | 8764.29 |
Property/Plant/Equipment, Total - Net | 3482.2 | 3221.6 | 2890.4 | 2575.8 | 2358.6 |
Property/Plant/Equipment, Total - Gross | 4880.3 | 4352.7 | 3812.8 | 3304.5 | 2924.9 |
Accumulated Depreciation, Total | -1398.1 | -1131.1 | -922.4 | -728.7 | -566.294 |
Long Term Investments | 6878 | 3194.8 | 3312.4 | 1800.5 | 1486.49 |
Other Long Term Assets, Total | 1059.7 | 967.8 | 913.3 | 910.6 | 584.157 |
Total Current Liabilities | 3932.5 | 2697.4 | 2096.6 | 1442.8 | 1135.48 |
Accounts Payable | 564 | 475.5 | 418.1 | 218.2 | 178.183 |
Accrued Expenses | 1880.5 | 1502.3 | 1037.4 | 751.3 | 636.668 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 719.7 | 0 | |||
Other Current Liabilities, Total | 768.3 | 719.6 | 641.1 | 473.3 | 320.632 |
Total Liabilities | 6666 | 6138 | 3715.5 | 2977.2 | 2620.21 |
Total Long Term Debt | 1980 | 2695.7 | 713.9 | 708.5 | 703.453 |
Capital Lease Obligations | 0 | 717.2 | 713.9 | 708.5 | 703.453 |
Other Liabilities, Total | 753.5 | 744.9 | 905 | 825.9 | 781.272 |
Total Equity | 18768.8 | 11025.3 | 11089.7 | 8757.3 | 6144.08 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.112 |
Additional Paid-In Capital | 8087.5 | 6716.2 | 4428.6 | 3911.6 | 3512.83 |
Retained Earnings (Accumulated Deficit) | 18968.3 | 10893 | 7379.8 | 5254.3 | 2946.73 |
Treasury Stock - Common | -8260.9 | -6613.3 | -739.9 | -396.4 | -316.24 |
Other Equity, Total | -26.2 | 29.3 | 21.1 | -12.3 | 0.64 |
Total Liabilities & Shareholders’ Equity | 25434.8 | 17163.3 | 14805.2 | 11734.5 | 8764.29 |
Total Common Shares Outstanding | 108.675 | 106.951 | 110.277 | 109.006 | 107.625 |
Long Term Debt | 1980 | 1978.5 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 14306 | 14014.9 | 13775.4 | 13337.6 | 10055.1 |
Denarna sredstva in kratkoročne naložbe | 7050.6 | 5694.7 | 5787.6 | 3910.8 | 3503.8 |
Denarna sredstva in ustrezniki | 3345.7 | 2885.6 | 3432.4 | 2072.2 | 1437.9 |
Kratkoročne naložbe | 3704.9 | 2809.1 | 2355.2 | 1838.6 | 2065.9 |
Celotne terjatve, neto | 4839 | 6036.5 | 5452 | 6998.6 | 4173 |
Accounts Receivable - Trade, Net | 4839 | 6036.5 | 5452 | 6998.6 | 4173 |
Total Inventory | 1465.7 | 1502.8 | 1550.1 | 1448.9 | 1665.3 |
Prepaid Expenses | 424.9 | 332.4 | 482 | 444.3 | 213.6 |
Other Current Assets, Total | 525.8 | 448.5 | 503.7 | 535 | 499.4 |
Total Assets | 26348.7 | 25434.8 | 23671.5 | 21485.9 | 17772.2 |
Property/Plant/Equipment, Total - Net | 3556.4 | 3482.2 | 3395.7 | 3358.5 | 3262.6 |
Long Term Investments | 7130.7 | 6878 | 5671.3 | 3940.3 | 3583.7 |
Other Long Term Assets, Total | 1355.6 | 1059.7 | 829.1 | 849.5 | 870.8 |
Total Current Liabilities | 3007.6 | 3932.5 | 3714.8 | 3732.4 | 3217.8 |
Accounts Payable | 470.3 | 564 | 427 | 476 | 542.9 |
Accrued Expenses | 2046 | 2206.8 | 2061 | 2018 | 1492.2 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 719.7 | 719 | 718.4 | 717.8 |
Other Current Liabilities, Total | 491.3 | 442 | 507.8 | 520 | 464.9 |
Total Liabilities | 6434 | 6666 | 6413.5 | 6358.6 | 5795.2 |
Total Long Term Debt | 2700.4 | 1980 | 1979.6 | 1979.2 | 1978.9 |
Long Term Debt | 1980.4 | 1980 | 1979.6 | 1979.2 | 1978.9 |
Capital Lease Obligations | 720 | 0 | 0 | 0 | 0 |
Other Liabilities, Total | 726 | 753.5 | 719.1 | 647 | 598.5 |
Total Equity | 19914.7 | 18768.8 | 17258 | 15127.3 | 11977 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
Additional Paid-In Capital | 8754.1 | 8087.5 | 7919.3 | 7225.8 | 6887.8 |
Retained Earnings (Accumulated Deficit) | 19941.8 | 18968.3 | 16739.3 | 15107.1 | 12008.2 |
Treasury Stock - Common | -8611.2 | -8260.9 | -7410.2 | -7221.4 | -6935.3 |
Other Equity, Total | -170.1 | -26.2 | 9.5 | 15.7 | 16.2 |
Total Liabilities & Shareholders’ Equity | 26348.7 | 25434.8 | 23671.5 | 21485.9 | 17772.2 |
Total Common Shares Outstanding | 109.507 | 108.675 | 108.527 | 106.72 | 106.644 |
- Letni
- Četrtletno
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Čisti prihodki/začetna postavka | 8075.3 | 3513.2 | 2115.8 | 2444.4 | 1198.51 |
Denarna sredstva iz poslovanja | 7081.3 | 2618.1 | 2430 | 2195.1 | 1307.11 |
Denarna sredstva iz poslovanja | 286.2 | 235.9 | 210.3 | 148.2 | 145.467 |
Deferred Taxes | -147.1 | 75.6 | -130.6 | -140 | 318.809 |
Nedenarne postavke | 783.4 | 297 | 435 | 439.5 | 570.858 |
Cash Taxes Paid | 1218.4 | 188.1 | 342.3 | 205.6 | 754.843 |
Denarna sredstva Plačane obresti | 55.8 | 23.2 | 25 | 22.3 | 18.678 |
Spremembe v obratnem kapitalu | -1916.5 | -1503.6 | -200.5 | -697 | -926.533 |
Denarna sredstva pri naložbenju | -5384.7 | -70.6 | -2027.8 | -1463 | -1005.18 |
Kapitalski izdatki | -551.9 | -614.6 | -429.6 | -383.1 | -272.626 |
Celotne druge postavke denarnih tokov pri naložbenju | -4832.8 | 544 | -1598.2 | -1079.9 | -732.556 |
Denarna sredstva pri financiranju | -1005.8 | -1970.5 | -252.1 | -77.1 | -24.4 |
Postavke denarnega toka pri financiranju | -1032.7 | -680.8 | -188 | -187.2 | -301.688 |
Izdaja (odplačilo) delnic, neto | 26.9 | -3271.6 | -64.1 | 110.1 | 240.213 |
Izdaja (odplačilo) dolga, neto | 0 | 1981.9 | 0 | 37.075 | |
Neto sprememba denarnih sredstev | 690.8 | 577 | 150.1 | 655 | 277.53 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | 973.5 | 8075.3 | 5846.3 | 4214.1 | 1115.2 |
Cash From Operating Activities | 2101.7 | 7081.3 | 4708.8 | 1295.2 | 668.5 |
Cash From Operating Activities | 74.3 | 286.2 | 211.7 | 138.5 | 67.4 |
Deferred Taxes | -225 | -147.1 | 58.8 | 51.8 | 10.1 |
Non-Cash Items | 455.7 | 783.4 | 153.1 | -84.9 | 15.2 |
Changes in Working Capital | 823.2 | -1916.5 | -1561.1 | -3024.3 | -539.4 |
Cash From Investing Activities | -1705.3 | -5384.7 | -3372 | -933.2 | -1059 |
Capital Expenditures | -141.8 | -551.9 | -397 | -263.8 | -115.3 |
Other Investing Cash Flow Items, Total | -1563.5 | -4832.8 | -2975 | -669.4 | -943.7 |
Cash From Financing Activities | 64.7 | -1005.8 | -99.2 | -484.6 | -366.4 |
Financing Cash Flow Items | -98.8 | -1032.7 | -450.3 | -180.7 | -154.5 |
Issuance (Retirement) of Stock, Net | 163.5 | 26.9 | 351.1 | -303.9 | -211.9 |
Net Change in Cash | 461.1 | 690.8 | 1237.6 | -122.6 | -756.9 |
Issuance (Retirement) of Debt, Net | 0 | 0 | 0 |
Ime vlagatelja | Vrsta vlagatelja | Odstotek neporavnanih obveznosti | Delnice v lasti | Sprememba delnic | Datum imetništva | Ocena prometa |
---|---|---|---|---|---|---|
Fidelity Management & Research Company LLC | Investment Advisor | 9.914 | 10658247 | 268103 | 2022-12-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 8.0656 | 8671077 | 74457 | 2022-12-31 | LOW |
Capital World Investors | Investment Advisor | 5.8065 | 6242435 | 16836 | 2022-12-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 5.7272 | 6157131 | -211997 | 2022-12-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 4.6145 | 4960885 | -90874 | 2022-12-31 | LOW |
JP Morgan Asset Management | Investment Advisor | 4.4213 | 4753254 | 301869 | 2022-12-31 | LOW |
Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 2.2475 | 2416247 | -27042 | 2022-12-31 | LOW |
Dodge & Cox | Investment Advisor/Hedge Fund | 2.0678 | 2223059 | -63450 | 2022-12-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 2.0538 | 2207990 | -32123 | 2022-12-31 | LOW |
T. Rowe Price Associates, Inc. | Investment Advisor | 1.4723 | 1582798 | -28736 | 2022-12-31 | LOW |
Capital International Investors | Investment Advisor | 1.4231 | 1529943 | -237193 | 2022-12-31 | LOW |
Invesco Capital Management (QQQ Trust) | Investment Advisor | 1.2962 | 1393537 | 7205 | 2023-02-28 | LOW |
Loomis, Sayles & Company, L.P. | Investment Advisor/Hedge Fund | 1.2443 | 1337681 | -378936 | 2022-12-31 | LOW |
Yancopoulos (George D) | Individual Investor | 1.1527 | 1239194 | -79973 | 2022-04-12 | LOW |
Putnam Investment Management, L.L.C. | Investment Advisor/Hedge Fund | 1.0395 | 1117533 | 13700 | 2022-12-31 | LOW |
American Century Investment Management, Inc. | Investment Advisor/Hedge Fund | 1.025 | 1102002 | -76069 | 2022-12-31 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.899 | 966467 | 1776 | 2022-12-31 | LOW |
BlackRock Asset Management Ireland Limited | Investment Advisor | 0.7992 | 859202 | -22201 | 2022-12-31 | LOW |
Legal & General Investment Management Ltd. | Investment Advisor/Hedge Fund | 0.7733 | 831369 | -41616 | 2022-12-31 | LOW |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.7213 | 775449 | -12042 | 2022-12-31 | LOW |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group500K+
Borzni posredniki
92K+
Aktivne stranke mesečno
$53M+
Mesečni obseg naložb
$30M+
Dvigi vsak mesec
Kalkulator trgovanja
Izračunajte svoj hipotetični P&L, če bi trgovino s CFD odprli na določen datum (izberite datum) in jo zaprli na drug datum (izberite datum).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Regeneron Company profile
O družbi Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. je integrirano biotehnološko podjetje, ki odkriva, izumlja, razvija, proizvaja in trži zdravila za hude bolezni. Komercializirana zdravila in izdelki v razvoju so namenjeni bolnikom z očesnimi boleznimi, alergijskimi in vnetnimi boleznimi, rakom, srčno-žilnimi in presnovnimi boleznimi, bolečinami, hematološkimi boleznimi, nalezljivimi boleznimi in redkimi boleznimi. Trženi izdelki družbe vključujejo zdravila EYLEA (aflibercept) injekcija, Dupixent (dupilumab) injekcija, Libtayo (cemiplimab) injekcija, Praluent (alirokumab) injekcija, REGEN-COV, Kevzara (sarilumab) raztopina za podkožno injiciranje, Evkeeza (evinakumab) injekcija, Inmazeb (atoltivimab, maftivimab in odesivimab-ebgn) injekcija, ARCALYST (rilonacept) injekcija za podkožno uporabo in ZALTRAP (ziv-aflibercept) injekcija za intravensko infuzijo. Njegovi izdelki v kliničnem razvoju so med drugim REGN4018, REGN5668 in Fasinumab.
Industry: | Bio Therapeutic Drugs |
777 Old Saw Mill River Road
TARRYTOWN
NEW YORK 10591
US
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 500.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com